These mice, however, lacked CEACAM6 that is usually co-overexpressed with CEA in cancers, had transgene expression levels that could have been below those observed in human tumors and lacked upstream and downstream genomic sequences in their transgenes that could have been necessary for derangement of their expression, e.g., in colonocytes with division potential. This evidence concerns the gene CEACAM3 and cancer.